Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital

Completed · Not applicable

Conditions studied: Herpes Zoster

In brief

The purpose of this study is to determine if vaccination rate of eligible patients at a major urban public hospital will increase by having ophthalmologists screen patients for eligibility and a nurse administer the vaccine in the General Eye Clinic.

Key facts

Study ID

NCT01483378

Run by

NYU Langone Health

People needed

170

Starts

2012-01-01

Expected to finish

2012-02-01

Last updated by the study team

2013-08-09

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 60 years of age or older
• Absence of evidence of immune compromise in the medical record
• Ability to speak and read English, Spanish or Chinese and give informed consent

You may not qualify if…

• Vulnerable patients, including the cognitively impaired, prisoners and employee
• FDA contraindications for Zostavax vaccine

Where it is running

• Bellevue Hospital — New York, New York, United States
• NYU Langone Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.